You can buy or sell XLRN and other stocks, options, ETFs, and crypto commission-free!
Acceleron Pharma Inc. Common Stock, also called Acceleron Pharma, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Read More Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. The listed name for XLRN is Acceleron Pharma Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 4, Pre-Market